Login

Recent searches

No recent searches

Search options

Only available when logged in.
fosstodon.org is one of the many independent Mastodon servers you can use to participate in the fediverse.
Fosstodon is an invite only Mastodon instance that is open to those who are interested in technology; particularly free & open source software. If you wish to join, contact us for an invite.

Administered by:

Server stats:

9.9K
active users

fosstodon.org: AboutStatusProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.7

#Ozempic

3 posts3 participants0 posts today
Public *
Maggie Maybe

The problem with the WARNING is that because of PBMs these #counterfeit products get distributed by pharmacies.

I don’t remember if it’s retail pharmacies or facility pharmacies where this kept happening, but there was a PBS Frontline documentary about how PBMs cause counterfeit medication to appear in legitimate supply chains.

So how would any of us know??

content.govdelivery.com/accoun

#FDA #recall (sort of)
#PBM #counterfeitMeds #ozempic

U.S. Food and Drug AdministrationFDA MedWatch - FDA Warns Consumers Not to Use Counterfeit Ozempic (semaglutide) Found in U.S. Drug Supply Chain
Public
DrBob, Neurologist, 🧠Mechanic

New Review and Meta-Analysis confirms weight gain with discontinuance of #Semaglutide and #Tirzepatide

Discontinuing GLP1 medications led to a pooled overall mean weight regain of 9.69 kg (or about 22 lbs in patients prescribed semaglutide/tirzepatide. The proportion of weight regained was proportional to the amount originally lost.

Discontinuation of GLP-1RA treatment leads to weight regain, regardless of lifestyle interventions, and should therefore be considered a chronic therapy to prevent weight regain and associated undesirable outcomes related to #Obesity.

#wegovy #ozempic #mounjaro #zepbound
onlinelibrary.wiley.com/doi/10

Text Shot: Summary Research on Glucagon-like peptide 1 receptor agonist (GLP-1RA) has mainly focused on the efficacy of weight loss and not the long-term efficacy of weight loss maintenance. This systematic review and meta-analysis aims to evaluate the sustainability of weight loss of patients taking GLP-1RAs following the discontinuation of the drug. EBSCOhost was used to simultaneously search Academic Search Premier, CINHAL Ultimate, Cochrane Central Register of Controlled Trials, MEDLINE with full text, Cochrane Database of Systematic Reviews, and separate PubMed search was systematically investigated using a predetermined search strategy from inception to February 1st, 2024. The authors extracted data regarding body weight change from baseline on treatment and off treatment, change in waist circumference from baseline on and off treatment, and change in BMI from baseline on and off treatment. Meta-analysis was conducted using RevMan (version 5.4) to calculate pooled mean…
Public
Maxi 10x 💉

»Und #Semaglutid ist der neue Schlüssel. Der von dicken Menschen, die sich das Hilfsmittel noch nicht leisten können, mit #Ozempic Shaming geneidet wird. Und von den mühelos Schlanken, die sich jetzt um Macht und Exklusivität sorgen, mit Ozempic Shaming als unnatürlich gebrandmarkt und bekämpft.«

sueddeutsche.de/kultur/ozempic (S+)

Süddeutsche Zeitung · Abnehmspritze Ozempic: Dünnsein ist eine Ressource von MachtBy Julia Werner
ExploreLive feeds
About